Status: current, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757375013 | Dapagliflozin propanediol monohydrate (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3757376014 | Dapagliflozin propanediol monohydrate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dapagliflozin propanediol monohydrate | Is a | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | ||
| Dapagliflozin propanediol monohydrate | Has disposition | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | ||
| Dapagliflozin propanediol monohydrate | Is modification of | Dapagliflozin propanediol | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dapagliflozin (as dapagliflozin propanediol monohydrate) 10 mg oral tablet | Has precise active ingredient | False | Dapagliflozin propanediol monohydrate | Inferred relationship | Some | 1 |
| Dapagliflozin (as dapagliflozin propanediol monohydrate) 5 mg oral tablet | Has precise active ingredient | False | Dapagliflozin propanediol monohydrate | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR